CIK 1910264
SR ONE CAPITAL MANAGEMENT, LP
Institutional 13F holdings & portfolio
Holdings
13
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–13 of 13
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc | 5.0M | $1M+ | SH |
| ACLX | Arcellx, Inc. | 2.3M | $1M+ | SH |
| CRSP | CRISPR Therapeutics AG | 2.0M | $1M+ | SH |
| DSGN | Design Therapeutics, Inc. | 6.5M | $1M+ | SH |
| MLYS | Mineralys Therapeutics Inc. | 1.6M | $1M+ | SH |
| SPRY | ARS Pharmaceuticals, Inc. | 4.0M | $1M+ | SH |
| ORIC | ORIC Pharmaceuticals, Inc. | 4.5M | $1M+ | SH |
| ALMS | Alumis Inc. | 2.0M | $1M+ | SH |
| ORKA | Oruka Therapeutics, Inc | 430K | $1M+ | SH |
| OCS | Oculis Holding AG | 641K | $1M+ | SH |
| ENGN | enGene Holdings Inc. | 748K | $1M+ | SH |
| NKTX | Nkarta, Inc. | 3.3M | $1M+ | SH |
| RARE | Ultragenyx Pharmaceutical Inc. | 138K | $1M+ | SH |